Tengion (TNGN) 0.2051 $TNGN Tengion Reports Fourth

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tengion (TNGN) 0.2051 $TNGN

Tengion Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Wed Mar 26, 3:05PM CDT
Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update.

Tallwave Expands High Tide Lean Business Competition to Include Ed Tech and Healthcare IT From Across the Country and Adds Industry Agnostic "Wildcard" Slots for Arizona IT Startups
Marketwire - Thu Mar 13, 2:14PM CDT
Tallwave today announced it is opening applications in its latest High Tide(TM) competition to Healthcare IT entrepreneurs from across the country. These entrepreneurs will join peers applying for the program in the previously announced focus on innovations in Ed Tech. In addition, Tallwave has reserved four to six slots for Arizona-only IT companies regardless of the industry sector they hail from. The deadline for submission is March 31, 2014 and can be completed online at www.tallwavehightide.com.

Tengion to Present at the 26th Annual ROTH Conference
GlobeNewswire - Tue Mar 04, 3:30PM CST
Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of Tengion, will present at the upcoming 26th Annual ROTH Conference on Monday, March 10, 2014, at 12:30 p.m. PDT in Dana Point, CA.

Global Stem Cell Market Report 2013
M2 - Tue Dec 17, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/qsfq7f/stem_cell_markets) has announced the addition of the "Global Stem Cell Market Report 2013" report to their offering. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. However, recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential. "Global Stem Cell Market Report 2013", describes the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. Key Topics Covered: 1. Overview 2. Biology of Stem Cells 3. Stem Cell Therapy 4. Market Analysis of the Stem Cell Space 5. Strategic Roadmap to Cell Therapy Industry 6. Funding for Regenerative Medicine Research 7. Current Stem Cell Research 8. Company Profiles Companies Mentioned: - Athersys, Inc - Brainstorm Cell Therapeutics, Inc - CryoLife, Inc - Epistem PLC - Forticell Bioscience, Inc - Glycosan Biosystems, Inc - Humacyte, Inc - International Stem Cell Corporation - Japan Tissue Engineering Co., Ltd - LifebankUSA - Miltenyi Biotec - Novocell, Inc - Osiris Therapeutics, Inc - Pluristem Therapeutics, Inc - ReNeuron Group Plc - Stempeutics Research Private Limited - Tengion, Inc - VistaGen Therapeutics, Inc - ZenBio, Inc For more information visit http://www.researchandmarkets.com/research/qs...ll_markets

Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
PR Newswire - Wed Aug 14, 3:05PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the second quarter ended June 30, 2013.

OTC Daily Alert Stock Watch - Tengion (OTCQB: TNGN)
WorldStockWire - Sat Aug 10, 7:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance
PR Newswire - Wed Aug 07, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance. Mr. Davis has served as Chief Financial Officer of Tengion since joining the Company in 2010 and recently helped facilitate the Company in raising $33.6M to fund research and development activities for its two lead clinical programs, the Neo-Kidney Augment(TM) and the Neo-Urinary Conduit(TM).

Market Maker Surveillance Report. OSTK, STXS, ZHNE, TNGN, GAME, HGSH, Winning Stocks With Lowest Price Friction For Thursday, July 18th 2013
M2 - Fri Jul 19, 2:05AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3821 companies with "abnormal" market making, 3241 companies with positive Friction Factors and 1918 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Overstock.com Inc (NASDAQ:OSTK), Stereotaxis Inc (NASDAQ:STXS), Zhone Technologies Inc (NASDAQ:ZHNE), Tengion Inc (OTC:TNGN), Shanda Games Ltd (NASDAQ:GAME), China Hgs Real Estate Inc (NASDAQ:HGSH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform(TM)
PR Newswire - Mon Jul 01, 1:41PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the closing of transactions totaling $33.6 million to fund its two lead clinical programs, the Neo-Kidney Augment(TM) and the Neo-Urinary Conduit(TM).

Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting
PR Newswire - Wed Jun 12, 3:30PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Dr. Tim Bertram, the Company's President of Research and Development and Chief Scientific Officer, will participate in a panel at the International Society for Stem Cell Research (ISSCR) 11th Annual Meeting being held June 12th-15th, 2013 in Boston, Massachusetts.

Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 15, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013.

Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
PR Newswire - Mon Apr 01, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the acceptance of the Company's Clinical Trial Application (CTA) filed with the Medical Products Agency (MPA) in Sweden to initiate a Phase 1 clinical trial to evaluate the safety and delivery of its Neo-Kidney Augment(TM) product in up to five patients with advanced chronic kidney disease (CKD).

Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
PR Newswire - Mon Mar 18, 6:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2012 and provided a business update.

Tengion to Present at 25th Annual ROTH Conference
PR Newswire - Tue Mar 12, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of Tengion, will present at the upcoming 25th Annual ROTH Conference on Tuesday, March 19, 2013, at 2:00 p.m. PDT in Laguna Niguel, CA.

Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
PR Newswire - Mon Mar 11, 3:00PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 18, 2013, at 9:00 a.m. EDT to provide a business update and discuss its fourth quarter and full year 2012 financial results.

Tengion to Present at the BIO CEO & Investor Conference
PR Newswire - Tue Feb 05, 7:00AM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that A. Brian Davis, Chief Financial Officer and Vice President, Finance of Tengion, will present at the upcoming BIO CEO & Investor Conference on Tuesday, February 12, 2013, at 10:30 a.m. EST in New York City.

Tengion Announces Clinical Progress for Neo-Urinary Conduit(TM) Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment(TM)
PR Newswire - Wed Jan 30, 3:30PM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced advances for its two lead programs, the Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM).

Tengion Announces Change to Board of Directors
PR Newswire - Fri Dec 21, 7:15AM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Scott D. Flora, President & Chief Executive Officer at OmniGuide, has resigned from Tengion's Board of Directors, effective December 19, 2012.

Regenerative Medicine - Global Strategic Business Report
M2 - Mon Dec 17, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/qhqtfr/regenerative) has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Regenerative Medicine in US$ million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as: - BioVest International Inc. - Curis Inc. - Cytori Therapeutics Inc. - Evotec AG - Forticell Bioscience Inc. - Geron Corporation - Integra LifeSciences Corporation - LifeCell Corporation - Osiris Therapeutics Inc. - Tengion Inc. - Tepha Inc. - TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public doma
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 168

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Allegations Against Symbotic Inc: The Investor Angle

Updated Category News Views 31

Allegations Rock Symbotic Inc. The ink is barely dry on the reports that some fat cats at Symbotic Inc. might've let their fingers get a bit too close to the cash till. There's a whirlwind brewing, pointing the finger squarely at the boardroom. Halper Sadeh LLC, the legal big shots known for scrutinizing shifty corporate moves, have thrown down the gauntlet, probing...

Continue Reading
David Lazar's Acquisition of Preferred Stock in Cyclacel

Updated Category News Views 210

Cyclacel Pharmaceuticals Engages Investor David Lazar for Preferred Stock Purchase Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has taken a notable step forward by entering into a strategic agreement with investor David Lazar for the acquisition of preferred stock. This agreement is heralding a new chapter in Cyclacel’s mission to develop innovative...

Continue Reading
TSC Alliance 50 Forward Fund Launches to Advance Research

Updated Category News Views 529

TSC Alliance Unveils 50 Forward Fund to Transform Research In a significant move aiming to revolutionize the lives of those affected by tuberous sclerosis complex (TSC), the TSC Alliance has launched the public phase of its 50 Forward Fund. This ambitious fundraising campaign is targeting a remarkable $40 million to drive forward research that promises to change the...

Continue Reading
What to Watch in the Stock Market Today - May 23, 2024

Updated Category Markets Views 359

Market Overview: Key Factors Influencing Stocks on May 23, 2024 Financial markets, especially the stock markets, are constantly fluctuating, and as it stands now, same for today, May 23, 2024. Market participants intend to deal for a number of earning calls, economic releases and geopolitical events that might turn the markets north or south. Thus, let’s go deeper into...

Continue Reading
Polish Stocks Surge as WIG30 Index Rises Significantly Today

Updated Category News Views 90

Positive Trends in Poland's Stock Market Today, the Polish stock market demonstrated a strong performance, with significant gains across multiple sectors as the day drew to a close. The WIG30 index, a prominent measure of stock performance in the nation, increased by 1.68%. This uplift was largely driven by growth in the Basic Materials, Construction, and Banking sectors....

Continue Reading